Get started
Author

Aikaterini Xydaki

Observed names: A Aikaterini Xydaki, A Xydaki, A. Xydaki, Xydaki, Aikaterini
ORCID: 0000-0002-6559-7026
Observed ORCID: 0000-0002-6559-7026
OpenAlex ID: A5075245105
Clinical significance of mutational variants in beta and alpha genes in patients with hemoglobinopathies from two large Greek centers: a complex interplay between genotype and phenotype
2023 · Michael D. Diamantidis, Rebecca-Anastasia Karanikola, et al. · Journal of Molecular Medicine · 18
PDF
Predisposing factors for advanced liver fibrosis in patients with sickle cell disease
2023 · Konstantinos Manganas, Sophia Delicou, et al. · British Journal of Haematology · 14
Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: A 12‐year study
2025 · Sophia Delicou, Konstantinos Manganas, et al. · British Journal of Haematology · 13
Severity of heart failure and health-related quality of life in beta-thalassemia patients: a cross-sectional study
2020 · Yannis Dimitroglou, Fotios Anagnostopoulos, et al. · Annals of Hematology · 11
Cellular and biochemical heterogeneity contributes to the phenotypic diversity of transfusion-dependent β-thalassemia
2025 · Konstantina Theocharaki, Alkmini T. Anastasiadi, et al. · Blood Advances · 10
PDF
Disorders of the erythrocyte membrane
2015 · Sophia Delicou, Aikaterini Xydaki, et al. · Italian Journal of Medicine · 10
PDF
Steroid-induced hypocalcaemia with tetany in a patient with hypoparathyroidism
2014 · Dimitrios Oikonomou, Ageliki Laina, et al. · BMJ Case Reports · 9
PDF
Adrenal Insufficiency in Patients with Beta Thalassemia: A Meta-Analysis
2024 · Christos Savvidis, Dimitra Ragia, et al. · Medicina · 7
PDF
Real-World Data on the Use of Luspatercept in Greek Patients with Transfusion Dependent Thalassemia
2022 · Polyxeni Delaporta, Alexandra Kourakli, et al. · Blood · 6
The Effect of COVID-19 on Hemoglobinopathy Patients’ Daily Lives While Quarantined: Four Greek Hospitals’ Experiences
2022 · Sophia Delicou, Aikaterini Xydaki, et al. · Thalassemia Reports · 6
PDF
Unveiling Extramedullary Hematopoiesis: A Case Report Highlighting the Causes, Symptoms, and Management Strategies
2024 · Konstantinos Manganas, Aikaterini Xydaki, et al. · Thalassemia Reports · 5
PDF
Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy
2022 · Konstantinos Manganas, Sophia Delicou, et al. · Hemoglobin · 4
Stratification of βSβ+ Compound Heterozygotes Based on L-Glutamine Administration and RDW: Focusing on Disease Severity
2023 · Aimilia Giannaki, Hara Τ. Georgatzakou, et al. · Antioxidants · 3
PDF
Epidemiological and comorbidity burden in transfusion-dependent patients with thalassemia and sickle cell disease in Greece
2026 · Sophia Delicou, Aikaterini Xydaki, et al. · Annals of Hematology · 2
PDF
Acute Painful Transfusion Reactions (APTRs): A Comprehensive Review of Clinical Features, Pathophysiology, Diagnosis, and Management
2025 · Sophia Delicou, Aspasia Argyrou, et al. · Thalassemia Reports · 2
PDF
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University Hospital
2021 · Sophia Delicou, Konstantina Aggeli, et al. · Hemoglobin · 2
Sickle-Cell Disease in Greece: Patient Reported Outcomes Related to Clinical Complications, Treatment Choices and Attitudes, Beliefs and Trends Affecting Potential Participation in Clinical Trials - a Greek National Multicentric Study
2019 · Sophia Delicou, Michael D. Diamantidis, et al. · Blood · 2
Aging With Thalassemia and Sickle Cell Disease: a Gerontological Model of Accelerated Multimorbidity and Function-centered Care Beyond Midlife
2026 · SOPHIA DELICOU, Ioannis Ilias, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 1
PDF
Quality of life in patients with transfusion-dependent hemoglobinopathies: evidence from an expert centre in Greece
2026 · Sophia Delicou, Aikaterini Xydaki, et al. · Transfusion Clinique et Biologique · 1
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRANSFUSION-DEPENDENT β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATIONS
2026 · Sophia Delicou, Aikaterini Xydaki, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 1
PDF
Treatment Options for Congenital Dyserythropoietic Anemias (CDAs): Advances in Bone Marrow Transplantation, Gene Therapy, and Targeted Therapies
2024 · Sophia Delicou, Maria Moraki, et al. · Journal of Hematology and Clinical Research · 1
PDF
P1506: Real-world Data on the Use of Luspatercept in Greek Patients With Transfusion Dependent Thalassemia
2022 · P. Delaporta, S. Delicou, et al. · HemaSphere · 1
Concerns Regarding the Management of β-Thalassaemia Patients in the Era of COVID-19
2020 · Constantina Aggeli, Sophia Delicou, et al. · EMJ Hematology · 1
PDF
‘Girdle Syndrome’ Progressing to Ischaemic Colitis and Acute Intrahepatic Cholestasis in a Patient with Sickle Cell Disease: A Case Report
2020 · Konstantinos Manganas, Sophia Delicou, et al. · EMJ Hematology · 1
PDF
Thalassemia Intermedia Caused by a Combination of a Globin Gene Triplication with Heterozygosity for β0 Thalassemia: A Case Report
2019 · Konstantinos Magganas, Sophia Delicou, et al. · OBM Genetics · 1
Works count: 36
Citation count: 132
H-index: 7
I10-index: 6
Year
Topic
Type